Industry / Bulgaria
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Heart Disease Remains Key Risk
February 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
New research in Bulgaria claims that up to 80% of the population over 40 years of age is at risk from heart disease. BMI believes that this indicator is worrying, but could result in an increased uptake of cardiology drugs, such as statins or hypertension treatments.